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ABSTRACT 
In this investigation fast dissolving tablets  were prepared using different Superdisintegrants like 
crospovidone, croscarmellose sodium and sodium starch glycolate by direct compression 
method. FDTs were evaluated for physicochemical properties like thickness, uniformity of 
weight, content uniformity ,hadness, friability, wetting time ,dispersion time in vitro 
disintegration time and in vitro dissolution. Wetting time of formulations containing 
Croscarmellose sodium was least and tablets showed fastest disintegration. The drug release 
from FDTs increased with increasing concentration of superdisintegrants and was found to be 
highest with formulations containing Croscarmellose sodium. The tablet disintegrated within 16 
to 45 seconds. Almost 96% of drug was released from the forumaltion within 16 min. The 
release of drug from FDTs was found to follow non-Fickian diffusion kinetics.Stability studies of 
the tablets shows non significant change. 
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INTRODUCTION 
Fast dispersing tablets(FDT) are novel type of tablets that disintegrate/dissolve /disperse in saliva 
within 15 to 60 s, when placed upon the tongue without the need of water. Due to this advantage 
of FDTs leads to their suitabilty for geriatric and pediatric patients at anytime, anywhere.[1-
3].Their growing importance was underlined recently when European pharmacopoeia adopted 
the term “Orodispersible tablet” as a tablet that to be place in the mouth where it disperses 
rapidly before swallowing. According to European pharmacopoeia, the ODT should disperse/ 
disintegarate in less than three minutes. United States Food and Drug Administration (FDA) 
define orally disintegrating tablets as “ A solid dosage form which contain a medicinal substance 
or active ingredient which disintegrates rapidly within a matter of seconds when placed upon the 
tongue”. US Food and Drug Administration Center for Drug Evaluation and research (CDER) 
defines, in the ‘ Orange Book’, an ODT as “a solid dosage form containing medicinal substance, 
which disintegrates rapidly, usaually within a matter of seconds, when placed upon the 
tongue”.[4] The bioavailability of some drugs may be increased due to absorption of drug in oral 
cavity and also due to pregastric absorption of saliva containing dispersed drugs that pass down 
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into the stomach. The amount of drug which is subjected to first pass metabolism is reduced as 
compared to conventional tablet.[5]. 
Drug is selective Beta-1 receptor antagonist. Activation of Beta-1 receptor by epinephrine 
increase the heart rate and blood pressure. Drug blocks these receptors which reverses the effect 
of epinephrine, lowering the heart rate and blood pressure. In addition beta blocker prevent the 
release of renin, which is a hormone produced by the kidneys which leads to constriction of 
blood vessels.[6] FdTs prepared by many techniques like freeze drying, sublimation, direct 
compression, spry drying ,tablet molding ,cotton calndy and mass extrusion..[7-8] Among these 
the dirct compression method is the better option for manufacturing of the FDTs because it has 
main advantage like low manufacturing cost and high mechanical integrity of the tablet. The fast 
dispersing tablet prepared by direct compression method. in general, are based on the action 
established by superdisintegrants such as croscarmellose sodium, and crospovidone. The effect 
of functionality differences of the superdisintegrants on tablet disintegration has been studied . 
The objective of the present work to develop  fast dispersing tablets by croscarmellose sodium, 
sodium starch glycolate and crospovidone are used as superdisintegrants. Effect of method of 
preparation on dissolution rate, disintegration time and wetting time was studied.[9]. 
MATERIAL AND METHOD  
Valdecoxib, Etoricoxib ,Meloxicam, Olanzapine those are marketed product. croscarmellose 
sodium, crospovidone,sodium starch glycolate ,dc mannitol , microcrystalline cellulose ,talc and 
magnesium stearate .[10] 
Preparation of tablets by direct compression method: Tablet containing 5 mg of Drug were 
prepared by direct compression method and the various formulae used in the study are shown 
in[Table 1]. The drug, diluents and superdisintegrants were pass through sieve no 44 saperatly 
and  properly mixed together (in a plastic container)., and In dry state , the drug with other 
ingredients was mixed for the period of 10min to get in uniformly mix powder. these powders 
were lubricated with magnesium stearate and talc and then finally raspberry was added. The 
tablets were prepared by direct compression method by manual feeding using 8 mm biconcave 
punches on a ‘Rimek mini press 1’ a 10 station rotary compression machine.  
EVALUATION : The prepared tablets were evaluated for hardness, thickness and diameter, 
friability, disintegration time, wetting time, drug content, in‐vitro dissolution studies, and 
stability studies. 
Thickness [11] 
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Thickness of tablets was important for uniformity of tablet size. Thickness was measured using 
screw gauge on randomly selected samples. 
Hardness [11] 
The resistance of tablet for shipping or breakage, under conditions of storage, transportation and 
handling, before usage, depends on its hardness. The hardness of tablet of each formulation was 
measured by monsanto hardness tester. Four tablets from each batch were selected and 
evaluated, and the average value with standard deviation was recorded.  
Friability [12] 
Friability is the measure of tablet strength. Roche friabilator was used for testing the friability 
using the following procedure. Twenty tablets were weighed accurately and placed in the 
tumbling apparatus that revolves at 25 rpm dropping the tablets through a distance of six inches 
with each revolution. After 4 min., the tablets were weighed and the percentage loss in tablet 
weight was determined. 
                                         Initial weight - Final weight 
          % Friability = ---------------------------------------- × 100 
                                                              Initial weight   
 
Weight variation [12] 
Twenty tablets were weighed individually and the average weight was determined. The % 
deviation was calculated and checked for weight variation as per IP.                               
Estimation of drug content [12] 
Estimation of drug content test as described in the IP was followed. Ten tablets were weighed 
and average weight was calculated. All tablets were crushed and powder equivalent to 10 mg 
drug was dissolved in 10 ml of 0.1N HCl and shaken for 1 h. From above solution 1 ml was 
withdrawn and diluted up to 10 ml and again withdraws 1 ml out of 10 ml and makes up to 10 ml 
with 0.1N HCl. Solution was filtered and absorbance was measured spectrophotometrically at 
281 nm against reagent blank. Amount of drug present in one tablet was calculated. 
 Disintegration test [12] 
Randomly six tablets were selected from each batch for disintegration test. Disintegration test 
was performed without disc in distilled water using USP disintegration apparatus.  
Wetting Time [13] 
Wetting time of dosage form is related with the contact angle. Wetting time of the mouth 
dissolving tablets is another important parameter, which needs to be assessed to give an insight 
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into the disintegration properties of the tablets; a lower wetting time implies a quicker 
disintegration of the tablet. The wetting time of the tablet can be measured using a simple 
procedure. 
Method: 
 Five circular tissue papers of 10 cm diameter are placed in a petridish with a 10 cm 
diameter. Ten ml of water containing Eosin, a water soluble dye is added to petridish. A tablet is 
carefully placed on the surface of the tissue paper. The time required for water to reach upper 
surface of the tablet is noted as wetting time. 
Water absorption ratio 
Water absorption ratio (R) is calculated using the formula 
R = 100 x [Wa – Wb] / Wb 
Where, Wa = weight of tablet after absorption 
  Wb = weight of tablet before absorption 
In vitro Dispersion time [14]   
The disintegration time for mouth dissolving tablets needs to be modified as disintegration is 
required without water, thus the test should mimic disintegration in salivary content. For this 
purpose, a Petridish (10 cm diameter) was filled with 9 ml of phosphate buffer solution, pH 6.8 
(which correlates pH of saliva). The tablet was carefully put in the center of Petridish and time 
for the tablet to completely disintegrate into fine particles was noted.  
 In vitro drug release [12] 
The in vitro release rate of Drugl from fast dispersing tablets was determined by using USP 
dissolution testing apparatus II (Paddle type). The dissolution test was performed using 500 ml 
of 0.1 N HCl, at 37 ± 0.5°C and 50 rpm. 2 ml aliquots were withdrawn from the dissolution 
apparatus and the samples were replaced with fresh dissolution medium. Sampling interval time 
was 2 min and withdrawn upto 16 min. Then, aliquots were filtered. After filtration, the amount 
of drug released was determined from the standard calibration curve of pure drug. 
STABILITY STUDY [15] 
Stability testing of drug products begins as a part of drug discovery and ends with the demise of 
the compound or commercial product. To assess the drug and formulation stability, stability 
studies were done according to ICH guidelines. The stability studies were carried out on the best 
formulation as per ICH guidelines. The most satisfactory formulation sealed in aluminum 
packaging and kept in humidity chamber maintained at 30 ± 2°C/65 ± 5 % RH and 40 ± 2°C/75 
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± 5 % RH for 2 months. The samples were analyzed for the drug content, in vitro dissolution 
studies, disintegration time and other physicochemical parameters after 30 days and 60 days. 





















Drug  5 5 5 5 5 5 5 5 5 5 
SSG 0 0 0 5.2 11.2 2.5 2.5 5.5 5.5 0 
Crospovidone 6 7.5 0 5.25 0 11.25 2.5 5.5 0 5.5 
CCS 7.5 0 7.5 5.25 0 0.75 6 0 5.5 5.5 
Mannitol 100.27 100.27 105 100 102 102 103 105 105 105 
MCC 27 27 27 25 25 25 25 25 25 25 
Magnesium stearate 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 
Talc 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 
Raspberry 0.5 0.5 1.15 1.5 1.5 1.15 1.15 1.15 1.15 1.15 
Aerosil 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 0.75 
Total wt. 150 150 150 150 150 150 150 150 150 150 
 
CONCLUSION  
In the present study, an attempt was made to prepare FDTs  in order to increase its onset of 
action by increasing its dissolution by its faster disintegration which is requirement for severe 
hypertensive condition and for better patient compliance, as it can be swallowed without the use 
of water.  
 The FDTs  were prepared by direct compression method using simplex lattice design. In 
these dosage form three superdisintegrating agent were used namely crospovidone, 
croscarmellose sodium and sodium starch glycolate in order to decrease the disintegration time. 
The process was carried out and the formula was prepared by the observed response and 
desirable values. The best formulation was found to be best in terms of cost effectiveness as one 
super disintegrant was used, disintegration time was found to be 17.16 sec with sufficient 
hardness, friability and release the maximum amount of the drug in 16 min. It showed no 
significant change in physicochemical properties, drug content, disintegrating time and in vitro 
dissolution pattern after storage at 30 ± 2°C/65 ± 5 % RH and at 40 ± 2°C/75 ± 5 % RH during 
stability studies for two months. Thus, the objective of the present investigation to design and 
prepared FDTs  was achieved. 
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